《半日速報》恆指升553點; 恆生科技指數升153點 平安升逾6% 港交所升逾6% 美團升逾4% 新東方在線創新高
恆指半日收16,714點,升553點或3.4%。恆生科技指數報3,417點,升153點或4.7%。國指升193點或3.5%,報5,676點。
活躍重磅股表現:
平安(02318.HK) 收36.8元,上升6.2%;
港交所(00388.HK) 收261.2元,上升6.1%;
美團(03690.HK) 收155.5元,上升4%;
友邦(01299.HK) 收67.95元,上升3.7%;
騰訊(00700.HK) 收247.2元,上升3.6%;
阿里巴巴(09988.HK) 收70.7元,上升1.1%;
異動恆指及國指成份股:
商湯-W(00020.HK) 收1.66元,上升24.8%;
碧桂園(02007.HK) 收1.45元,上升14.2%;
碧桂園服務(06098.HK) 收10.82元,上升12.7%;
快手-W(01024.HK) 收46.2元,上升10.3%;
嗶哩嗶哩-W(09626.HK) 收93.4元,上升9.9%;
舜宇(02382.HK) 收86.55元,上升9.6%;
藥明生物(02269.HK) 收46.65元,上升7.6%;
中國宏橋(01378.HK) 收6.68元,上升6.5%;
東方海外(00316.HK) 收129.3元,上升6.3%;
李寧(02331.HK) 收52.3元,上升5.9%;
吉利(00175.HK) 收10.86元,上升5.8%;
小米集團(01810.HK) 收10.26元,上升5.8%;
龍湖(00960.HK) 收13.48元,上升5.5%;
聯想集團(00992.HK) 收6.38元,上升5.5%;
信義光能(00968.HK) 收9.29元,上升5.4%;
京東集團(09618.HK) 收180.7元,上升5.3%;
匯控(00005.HK) 收43.55元,上升5.1%;
中升控股(00881.HK) 收36.45元,上升4.9%;
申洲(02313.HK) 收61.75元,上升4.7%;
中國海外發展(00688.HK) 收16.7元,上升4.5%;
中海油(00883.HK) 收10.3元,上升4.3%;
華潤置地(01109.HK) 收28.3元,上升4.2%;
海底撈(06862.HK) 收15.86元,上升4.2%;
京東健康(06618.HK) 收56.15元,上升4.2%;
郵儲銀行(01658.HK) 收4.12元,上升4%;
領展房產基金(00823.HK) 收51.8元,上升4%;
百度集團-SW(09888.HK) 收85.9元,上升4%;
信義玻璃(00868.HK) 收12.54元,上升4%;
中石油(00857.HK) 收3.3元,上升3.8%;
中國飛鶴(06186.HK) 收5.35元,上升3.7%;
創科(00669.HK) 收81.3元,上升3.6%;
信達生物(01801.HK) 收32.65元,上升3.5%;
阿里健康(00241.HK) 收4.18元,上升3.5%;
華潤啤酒(00291.HK) 收46.65元,上升3.4%;
招行(03968.HK) 收30.35元,上升3.4%;
安踏體育(02020.HK) 收80.45元,上升3.4%;
恆隆地產(00101.HK) 收11.12元,上升3.3%;
建行(00939.HK) 收4.41元,上升3.3%;
中燃(00384.HK) 收8元,上升3.2%;
周大福(01929.HK) 收15.46元,上升3.2%;
中銀香港(02388.HK) 收26元,上升3.2%;
網易(09999.HK) 收101.8元,上升3.1%;
中信股份(00267.HK) 收7.47元,上升3%;
異動綜合中小型股:
寶新金融(01282.HK) 收0.023元,上升21.1%;
阜博集團(03738.HK) 收3.73元,上升19.2%;
五礦資源(01208.HK) 收2元,上升19%;
華虹半導體(01347.HK) 收22.65元,上升15.1%;
微盟集團(02013.HK) 收4.56元,上升14.3%;
和鉑醫藥-B(02142.HK) 收1.14元,上升14%;
旭輝(00884.HK) 收0.54元,上升13.7%;
新城悅服務(01755.HK) 收5.11元,上升13.1%;
快狗打車(02246.HK) 收3.9元,上升13%;
國美零售(00493.HK) 收0.142元,上升12.7%;
招金(01818.HK) 收7.69元,上升12.4%;
旭輝永升服務(01995.HK) 收2.57元,上升12.2%;
紫金礦業(02899.HK) 收9.04元,上升11.7%;
福壽園(01448.HK) 收4.73元,上升11.3%;
合景悠活(03913.HK) 收0.99元,上升11.2%;
中梁控股(02772.HK) 收0.45元,上升11.1%;
中國有色礦業(01258.HK) 收3.41元,上升11.1%;
寶龍商業(09909.HK) 收3.33元,上升11%;
時代中國(01233.HK) 收0.61元,上升10.9%;
華潤醫療(01515.HK) 收4.27元,上升10.3%;
康希諾生物(06185.HK) 收123.5元,上升10.3%;
合景泰富(01813.HK) 收0.97元,上升10.2%;
新東方在線(01797.HK) 收45.25元,上升7.2%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.